nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB11—Doxorubicin—liver cancer	0.301	0.579	CbGbCtD
Clofazimine—ABCB11—bile canaliculus—liver cancer	0.173	0.63	CbGeAlD
Clofazimine—ABCB1—Sorafenib—liver cancer	0.085	0.164	CbGbCtD
Clofazimine—ABCB11—bile duct—liver cancer	0.054	0.197	CbGeAlD
Clofazimine—ABCB1—Doxorubicin—liver cancer	0.0516	0.0993	CbGbCtD
Clofazimine—CYP3A4—Sorafenib—liver cancer	0.0509	0.0981	CbGbCtD
Clofazimine—ABCB11—bile—liver cancer	0.0415	0.151	CbGeAlD
Clofazimine—CYP3A4—Doxorubicin—liver cancer	0.0309	0.0595	CbGbCtD
Clofazimine—Thromboembolism—Sorafenib—liver cancer	0.01	0.0849	CcSEcCtD
Clofazimine—Embolism venous—Sorafenib—liver cancer	0.00631	0.0535	CcSEcCtD
Clofazimine—Suicide—Sorafenib—liver cancer	0.00614	0.0521	CcSEcCtD
Clofazimine—Completed suicide—Sorafenib—liver cancer	0.00542	0.0459	CcSEcCtD
Clofazimine—ABCB11—Recycling of bile acids and salts—NR1H4—liver cancer	0.00528	0.06	CbGpPWpGaD
Clofazimine—ABCB11—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00503	0.0571	CbGpPWpGaD
Clofazimine—Embolism—Sorafenib—liver cancer	0.00496	0.0421	CcSEcCtD
Clofazimine—ABCB11—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00494	0.0562	CbGpPWpGaD
Clofazimine—ABCB11—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.0046	0.0523	CbGpPWpGaD
Clofazimine—ABCB11—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—NR1H4—liver cancer	0.00382	0.0433	CbGpPWpGaD
Clofazimine—Thromboembolism—Epirubicin—liver cancer	0.0037	0.0314	CcSEcCtD
Clofazimine—ABCB11—Synthesis of bile acids and bile salts—NR1H4—liver cancer	0.00347	0.0395	CbGpPWpGaD
Clofazimine—Thromboembolism—Doxorubicin—liver cancer	0.00343	0.029	CcSEcCtD
Clofazimine—ABCB11—liver—liver cancer	0.00338	0.0123	CbGeAlD
Clofazimine—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.00334	0.038	CbGpPWpGaD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00289	0.0328	CbGpPWpGaD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00284	0.0323	CbGpPWpGaD
Clofazimine—ABCB11—Bile acid and bile salt metabolism—NR1H4—liver cancer	0.00276	0.0313	CbGpPWpGaD
Clofazimine—Dermatitis exfoliative—Sorafenib—liver cancer	0.00245	0.0208	CcSEcCtD
Clofazimine—Embolism venous—Epirubicin—liver cancer	0.00233	0.0198	CcSEcCtD
Clofazimine—Embolism venous—Doxorubicin—liver cancer	0.00216	0.0183	CcSEcCtD
Clofazimine—Abdominal pain upper—Sorafenib—liver cancer	0.00211	0.0179	CcSEcCtD
Clofazimine—Hypokalaemia—Sorafenib—liver cancer	0.0021	0.0178	CcSEcCtD
Clofazimine—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.00201	0.0228	CbGpPWpGaD
Clofazimine—Embolism—Epirubicin—liver cancer	0.00183	0.0155	CcSEcCtD
Clofazimine—Weight decreased—Sorafenib—liver cancer	0.00181	0.0153	CcSEcCtD
Clofazimine—ABCB1—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.0018	0.0204	CbGpPWpGaD
Clofazimine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00177	0.0201	CbGpPWpGaD
Clofazimine—Jaundice—Sorafenib—liver cancer	0.00174	0.0147	CcSEcCtD
Clofazimine—Embolism—Doxorubicin—liver cancer	0.0017	0.0144	CcSEcCtD
Clofazimine—Neuralgia—Epirubicin—liver cancer	0.00169	0.0144	CcSEcCtD
Clofazimine—Hepatomegaly—Epirubicin—liver cancer	0.00166	0.0141	CcSEcCtD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00157	0.0179	CbGpPWpGaD
Clofazimine—Neuralgia—Doxorubicin—liver cancer	0.00157	0.0133	CcSEcCtD
Clofazimine—Hepatomegaly—Doxorubicin—liver cancer	0.00154	0.013	CcSEcCtD
Clofazimine—ABCB11—Recycling of bile acids and salts—ALB—liver cancer	0.0014	0.016	CbGpPWpGaD
Clofazimine—ABCB1—embryo—liver cancer	0.00134	0.00486	CbGeAlD
Clofazimine—Skin discolouration—Epirubicin—liver cancer	0.0013	0.0111	CcSEcCtD
Clofazimine—Anaemia—Sorafenib—liver cancer	0.00129	0.0109	CcSEcCtD
Clofazimine—Bone pain—Epirubicin—liver cancer	0.00123	0.0104	CcSEcCtD
Clofazimine—Skin discolouration—Doxorubicin—liver cancer	0.00121	0.0102	CcSEcCtD
Clofazimine—Cystitis noninfective—Epirubicin—liver cancer	0.00115	0.00975	CcSEcCtD
Clofazimine—Bone pain—Doxorubicin—liver cancer	0.00114	0.00964	CcSEcCtD
Clofazimine—Cystitis—Epirubicin—liver cancer	0.00114	0.00964	CcSEcCtD
Clofazimine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00111	0.0126	CbGpPWpGaD
Clofazimine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00109	0.0124	CbGpPWpGaD
Clofazimine—Anorexia—Sorafenib—liver cancer	0.00108	0.00918	CcSEcCtD
Clofazimine—ABCB1—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00107	0.0121	CbGpPWpGaD
Clofazimine—Bladder pain—Epirubicin—liver cancer	0.00106	0.00902	CcSEcCtD
Clofazimine—Cystitis noninfective—Doxorubicin—liver cancer	0.00106	0.00902	CcSEcCtD
Clofazimine—Cystitis—Doxorubicin—liver cancer	0.00105	0.00892	CcSEcCtD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00103	0.0117	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00103	0.0117	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00101	0.0115	CbGpPWpGaD
Clofazimine—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.00101	0.0115	CbGpPWpGaD
Clofazimine—Lymphadenopathy—Epirubicin—liver cancer	0.001	0.00849	CcSEcCtD
Clofazimine—Decreased appetite—Sorafenib—liver cancer	0.000988	0.00838	CcSEcCtD
Clofazimine—Bladder pain—Doxorubicin—liver cancer	0.000985	0.00835	CcSEcCtD
Clofazimine—Fatigue—Sorafenib—liver cancer	0.00098	0.00831	CcSEcCtD
Clofazimine—Constipation—Sorafenib—liver cancer	0.000972	0.00824	CcSEcCtD
Clofazimine—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000949	0.0108	CbGpPWpGaD
Clofazimine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00093	0.0106	CbGpPWpGaD
Clofazimine—Lymphadenopathy—Doxorubicin—liver cancer	0.000927	0.00786	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000906	0.00768	CcSEcCtD
Clofazimine—Body temperature increased—Sorafenib—liver cancer	0.000898	0.00762	CcSEcCtD
Clofazimine—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.000894	0.0102	CbGpPWpGaD
Clofazimine—CYP3A4—liver—liver cancer	0.000873	0.00318	CbGeAlD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000855	0.00971	CbGpPWpGaD
Clofazimine—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000854	0.00725	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000838	0.0071	CcSEcCtD
Clofazimine—Asthenia—Sorafenib—liver cancer	0.000815	0.00691	CcSEcCtD
Clofazimine—Pruritus—Sorafenib—liver cancer	0.000804	0.00682	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000791	0.0067	CcSEcCtD
Clofazimine—Abdominal pain upper—Epirubicin—liver cancer	0.00078	0.00662	CcSEcCtD
Clofazimine—Hypokalaemia—Epirubicin—liver cancer	0.000778	0.00659	CcSEcCtD
Clofazimine—Diarrhoea—Sorafenib—liver cancer	0.000778	0.00659	CcSEcCtD
Clofazimine—Dizziness—Sorafenib—liver cancer	0.000751	0.00637	CcSEcCtD
Clofazimine—ABCB11—Bile acid and bile salt metabolism—ALB—liver cancer	0.000734	0.00834	CbGpPWpGaD
Clofazimine—Eosinophilia—Epirubicin—liver cancer	0.000731	0.0062	CcSEcCtD
Clofazimine—Vomiting—Sorafenib—liver cancer	0.000723	0.00613	CcSEcCtD
Clofazimine—Abdominal pain upper—Doxorubicin—liver cancer	0.000722	0.00612	CcSEcCtD
Clofazimine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.000721	0.00819	CbGpPWpGaD
Clofazimine—Hypokalaemia—Doxorubicin—liver cancer	0.00072	0.0061	CcSEcCtD
Clofazimine—Rash—Sorafenib—liver cancer	0.000717	0.00608	CcSEcCtD
Clofazimine—Dermatitis—Sorafenib—liver cancer	0.000716	0.00607	CcSEcCtD
Clofazimine—Headache—Sorafenib—liver cancer	0.000712	0.00604	CcSEcCtD
Clofazimine—Eosinophilia—Doxorubicin—liver cancer	0.000677	0.00574	CcSEcCtD
Clofazimine—Nausea—Sorafenib—liver cancer	0.000675	0.00572	CcSEcCtD
Clofazimine—Photosensitivity reaction—Epirubicin—liver cancer	0.000674	0.00572	CcSEcCtD
Clofazimine—Weight decreased—Epirubicin—liver cancer	0.000668	0.00567	CcSEcCtD
Clofazimine—Hyperglycaemia—Epirubicin—liver cancer	0.000666	0.00565	CcSEcCtD
Clofazimine—Drowsiness—Epirubicin—liver cancer	0.000658	0.00558	CcSEcCtD
Clofazimine—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000656	0.00745	CbGpPWpGaD
Clofazimine—Jaundice—Epirubicin—liver cancer	0.000642	0.00544	CcSEcCtD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.000636	0.00722	CbGpPWpGaD
Clofazimine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.000633	0.00719	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000625	0.0071	CbGpPWpGaD
Clofazimine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000624	0.00529	CcSEcCtD
Clofazimine—Weight decreased—Doxorubicin—liver cancer	0.000618	0.00524	CcSEcCtD
Clofazimine—ABCB1—liver—liver cancer	0.000618	0.00225	CbGeAlD
Clofazimine—Hyperglycaemia—Doxorubicin—liver cancer	0.000616	0.00523	CcSEcCtD
Clofazimine—Drowsiness—Doxorubicin—liver cancer	0.000609	0.00517	CcSEcCtD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—NDRG1—liver cancer	0.000597	0.00678	CbGpPWpGaD
Clofazimine—Jaundice—Doxorubicin—liver cancer	0.000594	0.00504	CcSEcCtD
Clofazimine—Hepatitis—Epirubicin—liver cancer	0.000591	0.00501	CcSEcCtD
Clofazimine—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000585	0.00664	CbGpPWpGaD
Clofazimine—Visual impairment—Epirubicin—liver cancer	0.00057	0.00483	CcSEcCtD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000562	0.00639	CbGpPWpGaD
Clofazimine—Hepatitis—Doxorubicin—liver cancer	0.000547	0.00464	CcSEcCtD
Clofazimine—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00053	0.00602	CbGpPWpGaD
Clofazimine—Visual impairment—Doxorubicin—liver cancer	0.000527	0.00447	CcSEcCtD
Clofazimine—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000509	0.00579	CbGpPWpGaD
Clofazimine—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.000507	0.00576	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000488	0.00554	CbGpPWpGaD
Clofazimine—Anaemia—Epirubicin—liver cancer	0.000476	0.00403	CcSEcCtD
Clofazimine—ABCB1—Allograft Rejection—IL12A—liver cancer	0.000473	0.00537	CbGpPWpGaD
Clofazimine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000455	0.00517	CbGpPWpGaD
Clofazimine—Anaemia—Doxorubicin—liver cancer	0.00044	0.00373	CcSEcCtD
Clofazimine—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.000437	0.00496	CbGpPWpGaD
Clofazimine—Oedema—Epirubicin—liver cancer	0.00042	0.00356	CcSEcCtD
Clofazimine—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000414	0.0047	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—liver cancer	0.000414	0.0047	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000404	0.00459	CbGpPWpGaD
Clofazimine—Anorexia—Epirubicin—liver cancer	0.0004	0.00339	CcSEcCtD
Clofazimine—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000396	0.0045	CbGpPWpGaD
Clofazimine—Oedema—Doxorubicin—liver cancer	0.000389	0.00329	CcSEcCtD
Clofazimine—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000381	0.00432	CbGpPWpGaD
Clofazimine—Somnolence—Epirubicin—liver cancer	0.000373	0.00317	CcSEcCtD
Clofazimine—Anorexia—Doxorubicin—liver cancer	0.00037	0.00314	CcSEcCtD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00037	0.0042	CbGpPWpGaD
Clofazimine—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000366	0.00416	CbGpPWpGaD
Clofazimine—Decreased appetite—Epirubicin—liver cancer	0.000365	0.0031	CcSEcCtD
Clofazimine—Fatigue—Epirubicin—liver cancer	0.000362	0.00307	CcSEcCtD
Clofazimine—Constipation—Epirubicin—liver cancer	0.000359	0.00305	CcSEcCtD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000346	0.00394	CbGpPWpGaD
Clofazimine—Somnolence—Doxorubicin—liver cancer	0.000345	0.00293	CcSEcCtD
Clofazimine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—liver cancer	0.000338	0.00384	CbGpPWpGaD
Clofazimine—Decreased appetite—Doxorubicin—liver cancer	0.000338	0.00286	CcSEcCtD
Clofazimine—Fatigue—Doxorubicin—liver cancer	0.000335	0.00284	CcSEcCtD
Clofazimine—Constipation—Doxorubicin—liver cancer	0.000332	0.00282	CcSEcCtD
Clofazimine—Body temperature increased—Epirubicin—liver cancer	0.000332	0.00282	CcSEcCtD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000327	0.00372	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000314	0.00357	CbGpPWpGaD
Clofazimine—Body temperature increased—Doxorubicin—liver cancer	0.000307	0.0026	CcSEcCtD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000305	0.00347	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000303	0.00344	CbGpPWpGaD
Clofazimine—Asthenia—Epirubicin—liver cancer	0.000301	0.00255	CcSEcCtD
Clofazimine—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000298	0.00338	CbGpPWpGaD
Clofazimine—Pruritus—Epirubicin—liver cancer	0.000297	0.00252	CcSEcCtD
Clofazimine—ABCB1—Allograft Rejection—IL12B—liver cancer	0.000297	0.00337	CbGpPWpGaD
Clofazimine—Diarrhoea—Epirubicin—liver cancer	0.000287	0.00244	CcSEcCtD
Clofazimine—Asthenia—Doxorubicin—liver cancer	0.000279	0.00236	CcSEcCtD
Clofazimine—Dizziness—Epirubicin—liver cancer	0.000278	0.00235	CcSEcCtD
Clofazimine—Pruritus—Doxorubicin—liver cancer	0.000275	0.00233	CcSEcCtD
Clofazimine—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000272	0.00309	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	0.000269	0.00306	CbGpPWpGaD
Clofazimine—Vomiting—Epirubicin—liver cancer	0.000267	0.00226	CcSEcCtD
Clofazimine—Diarrhoea—Doxorubicin—liver cancer	0.000266	0.00225	CcSEcCtD
Clofazimine—Rash—Epirubicin—liver cancer	0.000265	0.00225	CcSEcCtD
Clofazimine—Dermatitis—Epirubicin—liver cancer	0.000265	0.00224	CcSEcCtD
Clofazimine—Headache—Epirubicin—liver cancer	0.000263	0.00223	CcSEcCtD
Clofazimine—Dizziness—Doxorubicin—liver cancer	0.000257	0.00218	CcSEcCtD
Clofazimine—Nausea—Epirubicin—liver cancer	0.000249	0.00212	CcSEcCtD
Clofazimine—Vomiting—Doxorubicin—liver cancer	0.000247	0.00209	CcSEcCtD
Clofazimine—Rash—Doxorubicin—liver cancer	0.000245	0.00208	CcSEcCtD
Clofazimine—Dermatitis—Doxorubicin—liver cancer	0.000245	0.00208	CcSEcCtD
Clofazimine—Headache—Doxorubicin—liver cancer	0.000243	0.00206	CcSEcCtD
Clofazimine—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000233	0.00264	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000233	0.00264	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000232	0.00263	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—UGDH—liver cancer	0.000231	0.00263	CbGpPWpGaD
Clofazimine—Nausea—Doxorubicin—liver cancer	0.000231	0.00196	CcSEcCtD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000228	0.00259	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.000227	0.00258	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	0.000221	0.00251	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00022	0.0025	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—EPT1—liver cancer	0.000217	0.00247	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000217	0.00247	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—TAT—liver cancer	0.000206	0.00234	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000203	0.0023	CbGpPWpGaD
Clofazimine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000195	0.00222	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000188	0.00214	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000178	0.00203	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000177	0.00201	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000174	0.00197	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000173	0.00197	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000171	0.00194	CbGpPWpGaD
Clofazimine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.00017	0.00193	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000169	0.00191	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000162	0.00184	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000158	0.00179	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000156	0.00178	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000156	0.00177	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000154	0.00175	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000152	0.00173	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000152	0.00172	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000147	0.00167	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000145	0.00165	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000143	0.00163	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GLUL—liver cancer	0.00014	0.00159	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CPT1B—liver cancer	0.00014	0.00159	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—NR1H4—liver cancer	0.000135	0.00153	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTA3—liver cancer	0.000133	0.00151	CbGpPWpGaD
Clofazimine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.00013	0.00148	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000128	0.00146	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	0.000127	0.00145	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000122	0.00138	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTA4—liver cancer	0.000121	0.00138	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000119	0.00135	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000119	0.00135	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTA2—liver cancer	0.000118	0.00134	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000116	0.00132	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTA1—liver cancer	0.000114	0.0013	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000114	0.00129	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000114	0.00129	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—CASP3—liver cancer	0.000114	0.00129	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—IL2—liver cancer	0.000113	0.00129	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—NAT2—liver cancer	0.000113	0.00128	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.000111	0.00126	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000109	0.00124	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000109	0.00124	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000109	0.00123	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ALDOB—liver cancer	0.000108	0.00123	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CRABP1—liver cancer	0.000103	0.00117	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000103	0.00117	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	9.78e-05	0.00111	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—VEGFA—liver cancer	9.64e-05	0.0011	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	9.47e-05	0.00108	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	9.34e-05	0.00106	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.3e-05	0.00106	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—HPGDS—liver cancer	9.02e-05	0.00102	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.97e-05	0.00102	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—TGFB1—liver cancer	8.85e-05	0.00101	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GGT1—liver cancer	8.7e-05	0.000988	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	8.58e-05	0.000974	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	8.42e-05	0.000956	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—TNF—liver cancer	8.26e-05	0.000939	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—UGDH—liver cancer	8.26e-05	0.000938	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.17e-05	0.000928	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.07e-05	0.000916	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PSMD10—liver cancer	8.04e-05	0.000914	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PSMA4—liver cancer	8.04e-05	0.000914	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	7.96e-05	0.000904	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GOT2—liver cancer	7.82e-05	0.000889	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTP1—liver cancer	7.81e-05	0.000887	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—EPT1—liver cancer	7.77e-05	0.000882	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	7.7e-05	0.000875	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—TAT—liver cancer	7.36e-05	0.000836	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP2E1—liver cancer	7.36e-05	0.000836	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTM1—liver cancer	7.18e-05	0.000815	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.12e-05	0.000809	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	7.1e-05	0.000807	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	7.08e-05	0.000804	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYCS—liver cancer	6.88e-05	0.000782	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	6.8e-05	0.000773	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GOT1—liver cancer	6.75e-05	0.000767	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GGT1—liver cancer	6.75e-05	0.000767	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	6.71e-05	0.000762	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	6.24e-05	0.000709	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTP1—liver cancer	6.07e-05	0.000689	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—HMOX1—liver cancer	5.98e-05	0.00068	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	5.72e-05	0.00065	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	5.61e-05	0.000637	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTM1—liver cancer	5.57e-05	0.000633	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	5.46e-05	0.00062	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	5.45e-05	0.000619	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	5.4e-05	0.000614	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP1A1—liver cancer	5.28e-05	0.0006	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	5.28e-05	0.0006	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	5.25e-05	0.000597	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	5.15e-05	0.000585	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—UGDH—liver cancer	5.09e-05	0.000578	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GLUL—liver cancer	5e-05	0.000568	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CPT1B—liver cancer	5e-05	0.000568	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—MTHFR—liver cancer	4.93e-05	0.00056	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PPARA—liver cancer	4.83e-05	0.000549	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—NR1H4—liver cancer	4.83e-05	0.000548	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—EPT1—liver cancer	4.78e-05	0.000544	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	4.76e-05	0.00054	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTA3—liver cancer	4.74e-05	0.000539	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	4.57e-05	0.000519	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—TAT—liver cancer	4.54e-05	0.000515	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	4.38e-05	0.000497	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	4.37e-05	0.000496	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.34e-05	0.000493	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTA4—liver cancer	4.34e-05	0.000493	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTA2—liver cancer	4.23e-05	0.00048	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PIK3CG—liver cancer	4.14e-05	0.00047	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTA1—liver cancer	4.08e-05	0.000463	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	4.08e-05	0.000463	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	4.04e-05	0.000459	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—NAT2—liver cancer	4.03e-05	0.000458	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PPARG—liver cancer	4e-05	0.000454	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ALDOB—liver cancer	3.87e-05	0.000439	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.72e-05	0.000422	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CRABP1—liver cancer	3.69e-05	0.000419	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	3.69e-05	0.000419	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PIK3CD—liver cancer	3.64e-05	0.000413	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	3.59e-05	0.000408	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ALB—liver cancer	3.59e-05	0.000408	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—HPGDS—liver cancer	3.22e-05	0.000366	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PIK3CB—liver cancer	3.17e-05	0.00036	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CPT1B—liver cancer	3.08e-05	0.00035	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GLUL—liver cancer	3.08e-05	0.00035	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.04e-05	0.000345	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—NR1H4—liver cancer	2.97e-05	0.000338	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTA3—liver cancer	2.92e-05	0.000332	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PSMD10—liver cancer	2.87e-05	0.000326	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PSMA4—liver cancer	2.87e-05	0.000326	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GOT2—liver cancer	2.8e-05	0.000318	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.74e-05	0.000311	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTA4—liver cancer	2.67e-05	0.000304	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP2E1—liver cancer	2.63e-05	0.000299	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTA2—liver cancer	2.61e-05	0.000296	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTA1—liver cancer	2.51e-05	0.000286	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—NAT2—liver cancer	2.49e-05	0.000282	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.48e-05	0.000282	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYCS—liver cancer	2.46e-05	0.000279	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GGT1—liver cancer	2.41e-05	0.000274	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GOT1—liver cancer	2.41e-05	0.000274	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ALDOB—liver cancer	2.38e-05	0.000271	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CRABP1—liver cancer	2.27e-05	0.000258	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTP1—liver cancer	2.17e-05	0.000246	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—HMOX1—liver cancer	2.14e-05	0.000243	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTM1—liver cancer	1.99e-05	0.000226	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—HPGDS—liver cancer	1.99e-05	0.000226	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PIK3CA—liver cancer	1.93e-05	0.00022	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP1A1—liver cancer	1.89e-05	0.000215	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PSMA4—liver cancer	1.77e-05	0.000201	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PSMD10—liver cancer	1.77e-05	0.000201	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—MTHFR—liver cancer	1.76e-05	0.0002	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PPARA—liver cancer	1.73e-05	0.000196	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GOT2—liver cancer	1.72e-05	0.000196	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.62e-05	0.000184	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—AKT1—liver cancer	1.58e-05	0.000179	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYCS—liver cancer	1.52e-05	0.000172	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GOT1—liver cancer	1.49e-05	0.000169	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GGT1—liver cancer	1.49e-05	0.000169	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PIK3CG—liver cancer	1.48e-05	0.000168	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PPARG—liver cancer	1.43e-05	0.000162	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTP1—liver cancer	1.34e-05	0.000152	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—HMOX1—liver cancer	1.32e-05	0.00015	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PIK3CD—liver cancer	1.3e-05	0.000148	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ALB—liver cancer	1.28e-05	0.000146	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTM1—liver cancer	1.23e-05	0.000139	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.16e-05	0.000132	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PIK3CB—liver cancer	1.13e-05	0.000129	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—MTHFR—liver cancer	1.08e-05	0.000123	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PPARA—liver cancer	1.06e-05	0.000121	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PIK3CG—liver cancer	9.11e-06	0.000104	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PPARG—liver cancer	8.8e-06	9.99e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PIK3CD—liver cancer	8.01e-06	9.1e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ALB—liver cancer	7.91e-06	8.98e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PIK3CB—liver cancer	6.98e-06	7.93e-05	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PIK3CA—liver cancer	6.91e-06	7.85e-05	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—AKT1—liver cancer	5.65e-06	6.41e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PIK3CA—liver cancer	4.26e-06	4.84e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—AKT1—liver cancer	3.48e-06	3.95e-05	CbGpPWpGaD
